Coherus Biosciences













What can you tell us about what is going on at Coherus? Will they continue with KBI on their generic version of Neulasta?

Their financial statement says the following:
"We have engaged a single contract manufacturer, KBI Biopharma, Inc., to manufacture and supply clinical trial quantities of the biological substance in CHS-1701 as well as quantities of the material necessary for process validation. However, we have not yet engaged a contract manufacturer to supply clinical trial quantities of the final (filled and finished) biosimilar drug product for CHS-1701. "

With all of the compliance challenges at KBI, I wonder if Coherus is re-thinking the use of KBI.